The Exchange has decided that the trading in shares of Serendex Pharmaceuticals A/S (SENDEXo, ISIN code DK0060563427, order book ID101906) shall be resumed.
For further information concerning this exchange notice please contact Issuer Surveillance Stockholm, telephone +46 8 405 60 00, or iss@nasdaq.com.
NASDAQ OMX Stockholm AB